OTCMKTS:DOCRF

CloudMD Software & Services Competitors

$1.61
-0.05 (-3.02 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.59
Now: $1.61
$1.67
50-Day Range
$1.38
MA: $1.68
$2.12
52-Week Range
$0.31
Now: $1.61
$2.61
Volume212,559 shs
Average Volume452,559 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

CloudMD Software & Services (OTCMKTS:DOCRF) Vs. BNVIF, CNONF, EVAHF, EWLL, FORA, and MTHRF

Should you be buying DOCRF stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to CloudMD Software & Services, including Binovi Technologies (BNVIF), CannaOne Technologies (CNONF), EGF Theramed Health (EVAHF), eWellness Healthcare (EWLL), Forian (FORA), and M3 (MTHRF).

Binovi Technologies (OTCMKTS:BNVIF) and CloudMD Software & Services (OTCMKTS:DOCRF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Earnings and Valuation

This table compares Binovi Technologies and CloudMD Software & Services' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Binovi TechnologiesN/AN/AN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Binovi Technologies and CloudMD Software & Services, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Binovi Technologies0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus target price of $3.3750, indicating a potential upside of 110.28%. Given CloudMD Software & Services' higher possible upside, analysts plainly believe CloudMD Software & Services is more favorable than Binovi Technologies.

Profitability

This table compares Binovi Technologies and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Binovi TechnologiesN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Summary

CloudMD Software & Services beats Binovi Technologies on 2 of the 2 factors compared between the two stocks.

CannaOne Technologies (OTCMKTS:CNONF) and CloudMD Software & Services (OTCMKTS:DOCRF) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.

Profitability

This table compares CannaOne Technologies and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CannaOne TechnologiesN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for CannaOne Technologies and CloudMD Software & Services, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CannaOne Technologies0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus target price of $3.3750, suggesting a potential upside of 110.28%. Given CloudMD Software & Services' higher possible upside, analysts plainly believe CloudMD Software & Services is more favorable than CannaOne Technologies.

Earnings and Valuation

This table compares CannaOne Technologies and CloudMD Software & Services' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CannaOne TechnologiesN/AN/AN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

Summary

CloudMD Software & Services beats CannaOne Technologies on 2 of the 2 factors compared between the two stocks.

EGF Theramed Health (OTCMKTS:EVAHF) and CloudMD Software & Services (OTCMKTS:DOCRF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares EGF Theramed Health and CloudMD Software & Services' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EGF Theramed HealthN/AN/AN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for EGF Theramed Health and CloudMD Software & Services, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
EGF Theramed Health0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus target price of $3.3750, indicating a potential upside of 110.28%. Given CloudMD Software & Services' higher probable upside, analysts clearly believe CloudMD Software & Services is more favorable than EGF Theramed Health.

Profitability

This table compares EGF Theramed Health and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EGF Theramed HealthN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Summary

CloudMD Software & Services beats EGF Theramed Health on 2 of the 2 factors compared between the two stocks.

eWellness Healthcare (OTCMKTS:EWLL) and CloudMD Software & Services (OTCMKTS:DOCRF) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation.

Profitability

This table compares eWellness Healthcare and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
eWellness HealthcareN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Valuation and Earnings

This table compares eWellness Healthcare and CloudMD Software & Services' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
eWellness HealthcareN/AN/AN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for eWellness Healthcare and CloudMD Software & Services, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
eWellness Healthcare0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus target price of $3.3750, suggesting a potential upside of 110.28%. Given CloudMD Software & Services' higher possible upside, analysts clearly believe CloudMD Software & Services is more favorable than eWellness Healthcare.

Summary

CloudMD Software & Services beats eWellness Healthcare on 2 of the 2 factors compared between the two stocks.

Forian (NASDAQ:FORA) and CloudMD Software & Services (OTCMKTS:DOCRF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, profitability, risk and analyst recommendations.

Profitability

This table compares Forian and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ForianN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for Forian and CloudMD Software & Services, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Forian0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus price target of $3.3750, indicating a potential upside of 110.28%. Given CloudMD Software & Services' higher possible upside, analysts plainly believe CloudMD Software & Services is more favorable than Forian.

Valuation & Earnings

This table compares Forian and CloudMD Software & Services' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ForianN/AN/AN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

Summary

CloudMD Software & Services beats Forian on 2 of the 2 factors compared between the two stocks.

M3 (OTCMKTS:MTHRF) and CloudMD Software & Services (OTCMKTS:DOCRF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, profitability, risk and analyst recommendations.

Analyst Recommendations

This is a summary of recent recommendations and price targets for M3 and CloudMD Software & Services, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
M300303.00
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus price target of $3.3750, indicating a potential upside of 110.28%. Given CloudMD Software & Services' higher possible upside, analysts plainly believe CloudMD Software & Services is more favorable than M3.

Valuation & Earnings

This table compares M3 and CloudMD Software & Services' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
M3N/AN/AN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

Profitability

This table compares M3 and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
M3N/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A


CloudMD Software & Services Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06-0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$1.01-3.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11-0.0%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
EWLL
eWellness Healthcare
0.6$0.00-0.0%$0.00N/A0.00Gap Up
FORA
Forian
0.3$12.05-0.5%$0.00N/A0.00
M3 logo
MTHRF
M3
1.0$76.00-0.0%$0.00N/A0.00
NEWUF
Newtopia
1.7$0.41-0.0%$0.00N/A0.00
PANHF
Ping An Healthcare and Technology
1.0$12.20-0.0%$0.00N/A0.00
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.65-0.0%$0.00N/A0.00Decrease in Short Interest
CBIIF
Skylight Health Group
0.0$0.92-3.3%$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
UCBB
US-China Biomedical Technology
0.3$0.13-0.0%$0.00N/A0.00
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$5.88-2.0%$0.00N/A0.00
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.